Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 16;18(10):e202300169.
doi: 10.1002/asia.202300169. Epub 2023 Apr 26.

Targeting multidrug resistant Staphylococcus aureus with cationic chlorpromazine-peptide conjugates

Apurva Panjla  1 , Grace Kaul  2   3 , Abdul Akhir  4 , Deepanshi Saxena  2 , Saurabh Joshi  1 , Chandrima Modak  5 , Dipti Kumari  5 , Alok Jain  5 , Sidharth Chopra  2   3 , Sandeep Verma  1   4
Affiliations

Targeting multidrug resistant Staphylococcus aureus with cationic chlorpromazine-peptide conjugates

Apurva Panjla et al. Chem Asian J. .

Abstract

Antimicrobial resistance is a serious public health risk. Its severity is fueled on an unprecedented scale, necessitating the demand for novel antimicrobial scaffolds aimed at novel targets. Herein, we present cationic chlorpromazine peptide conjugates that are rationally intended to targetmultidrug-resistant (MDR) bacteria. The most potent compound, CPWL, of all the conjugates evaluated, showed promising antibacterial activity against clinical, MDR S. aureus, with no cytotoxicity. The molecular docking experiments confirmed that CPWL possessed a very high affinity for S. aureus enoyl reductase (saFabI). Furthermore, CPWL antibacterial action against saFabI was further corroborated by MD simulation studies. Thus, our findings highlight cationic chlorpromazine as a promising scaffold for the development of saFabI inhibitors to target severe staphylococcal infections.

Keywords: Antimicrobial resistance; antibiotics; membrane proteins; peptide.

PubMed Disclaimer

References

    1. None
    1. H. De Lencastre, D. Oliveira, A. Tomasz, Curr. Opin. Microbiol. 2007, 10, 428-435;
    1. H. W. Boucher, G. H. Talbot, J. S. Bradley, J. E. Edwards, D. Gilbert, L. B. Rice, M. Scheld, B. Spellberg, J. Bartlett, Clin. Infect. Dis. 2009, 48, 1-12.
    1. T. L. Holland, A. S. Bayer, V. G. Fowler Jr, Clin. Infect. Dis. 2022, 75, 1668-1674.
    1. A. J. Sabat, M. Tinelli, H. Grundmann, V. Akkerboom, M. Monaco, M. Del Grosso, G. Errico, A. Pantosti, A. W. Friedrich, Front. Microbiol. 2018, 9, 2705.

MeSH terms

LinkOut - more resources